# A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring

> **NCT06710470** · — · ACTIVE_NOT_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 833 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Deucravacitinib
- **DRUG:** Systemic psoriasis medications
- **OTHER:** No systemic medications

## Key facts

- **NCT ID:** NCT06710470
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-02
- **Primary completion:** 2027-01-31
- **Final completion:** 2029-02-28
- **Target enrollment:** 833 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710470, "A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06710470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*